Imvax is a Philadelphia-based biotechnology company that specializes in developing vaccines and immunotherapy techniques to treat previously untreatable forms of cancer. Imvax engaged with Watchdog to manage the design and construction of their new headquarters and primary research and development (R&D) lab at the historic Curtis Center in Old City, Philadelphia.
The primary challenge for the team to overcome was placing a state-of-the-art R&D facility in a historic building that was once home to the printing equipment that published magazines such as The Saturday Evening Post. This was further compounded by Imvax’s space being on the 4th floor of an 11-story building. Exhaust systems and ductwork had to be run through an abandoned elevator shaft to rise up the (7) stories to access the roof. Watchdog was instrumental in working with the design and contractor teams to ensure that Imvax’s vision was met and the budget was properly managed throughout the process.
Watchdog’s diverse expertise was able to help Imvax deliver one of the first biotechnology spaces to an area of Philadelphia that is working to draw more tech-based companies. This space will add to the unique diversity and amenities that exist in Old City.